Acute lung injury (ALI) is a clinically life-threatening
form of
respiratory failure with a mortality of 30%–40%. Acute respiratory
distress syndrome is the aggravated form of ALI. Exosomes are extracellular
lipid vesicles ubiquitous in human biofluids with a diameter of 30–150
nm. They can serve as carriers to convey their internal cargo, particularly
microRNA (miRNA), to the target cells involved in cellular communication.
In disease states, the quantities of exosomes and the cargo generated
by cells are altered. These exosomes subsequently function as autocrine
or paracrine signals to nearby or distant cells, regulating various
pathogenic processes. Moreover, exosomal miRNAs from multiple stem
cells can provide therapeutic value for ALI by regulating different
signaling pathways. In addition, changes in exosomal miRNAs of biofluids
can serve as biomarkers for the early diagnosis of ALI. This study
aimed to review the role of exosomal miRNAs produced by different
sources participating in various pathological processes of ALI and
explore their potential significance in the treatment and diagnosis.